Literature DB >> 16421372

Reducing the risk of gynecologic cancer in the Lynch syndrome.

Kenneth Offit, Noah D Kauff.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16421372     DOI： 10.1056/NEJMe058284

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Reproductive Decision-Making in MMR Mutation Carriers After Results Disclosure: Impact of Psychological Status in Childbearing Options.

Authors:  Jacqueline Duffour; Audrey Combes; Evelyne Crapez; Florence Boissière-Michot; Frédéric Bibeau; Pierre Senesse; Marc Ychou; Julie Courraud; Hélène de Forges; Lise Roca
Journal:  J Genet Couns       Date:  2015-09-22       Impact factor: 2.537

Review 2.  Prophylactic surgery in Lynch syndrome.

Authors:  V Celentano; G Luglio; G Antonelli; R Tarquini; L Bucci
Journal:  Tech Coloproctol       Date:  2011-02-02       Impact factor: 3.781

Review 3.  Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.

Authors:  Jeffrey N Weitzel; Kathleen R Blazer; Deborah J MacDonald; Julie O Culver; Kenneth Offit
Journal:  CA Cancer J Clin       Date:  2011-08-19       Impact factor: 508.702

4.  Risk-reducing surgery in hereditary gynecological cancer: Clinical applications in Lynch syndrome and hereditary breast and ovarian cancer.

Authors:  Masataka Adachi; Kouji Banno; Megumi Yanokura; Miho Iida; Kanako Nakamura; Yuya Nogami; Kiyoko Umene; Kenta Masuda; Iori Kisu; Arisa Ueki; Akira Hirasawa; Eiichiro Tominaga; Daisuke Aoki
Journal:  Mol Clin Oncol       Date:  2014-11-20

5.  A retrospective study of extracolonic, non-endometrial cancer in Swedish Lynch syndrome families.

Authors:  Masoud Karimi; Jenny von Salomé; Christos Aravidis; Gustav Silander; Marie Stenmark Askmalm; Isabelle Henriksson; Samuel Gebre-Medhin; Jan-Erik Frödin; Erik Björck; Kristina Lagerstedt-Robinson; Annika Lindblom; Emma Tham
Journal:  Hered Cancer Clin Pract       Date:  2018-10-23       Impact factor: 2.857
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.